100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory

dc.contributor.authorFerraz, Maria da Gloria Mattosinho de Castropor
dc.contributor.authorDall' Agnol, Miriapor
dc.contributor.authordi Loreto, Celsopor
dc.contributor.authorPirani, Wiliam M.por
dc.contributor.authorUtagawa, Maria Lúciapor
dc.contributor.authorPereira, Sonia Maria Mirandapor
dc.contributor.authorSakai, Yuriko Itopor
dc.contributor.authorFeres, Camilo Lelispor
dc.contributor.authorShih, Lai W. S.por
dc.contributor.authorYamamoto, Luzia Setukopor
dc.contributor.authorRodrigues, Rosemeire O. L.por
dc.contributor.authorShirata, Neuza Kasumipor
dc.contributor.authorLongatto, Adhemarpor
dc.date.accessioned2020-10-30T10:14:51Z
dc.date.issued2005
dc.description.abstractTo verij5 the efficacy of the quality control (QC) program in a cytologic laboratwy with a rapid rescreening (RR) protocol. To verij5 the efficacy of the quality control (QC) program in a cytologic laboratwy with a rapid rescreening (RR) protocol.RR, according to the Turret RR method, of all samples initially screened as negative at the Laboratory of Cytology, Adolfo Lutz Institute, was performed. The slides were reviewed for 60 seconds. Suspect smears were fully checked by 2 reviewers to determine the final diagnoses. A total of 2954 sequential cytologic results were considered in this study. Of the 2954, 2568 (86.9%) were considered initially negative according to our internal QC, and these cases underwent RR. Also, 10% were randomly selected from these negative cases for full reviewing. The internal QC in our laboratory includes review of cases selected according to clinical and cytomorphologic criteria.Among the 2954 total cases, QC detected 386 (13%) atypias with final diagnoses reported according to The Bethesda System 2001 as follows: 82 (2.18%) low grade squamous intraepithelial lesions (LSILs), 35 (1.18%) high grade squamous intraepithelial lesions (HSILs), 2 (0.06%) squamous cell carcinomas, 105 (3.5%) atypical cells of undetermined significance (ASC-US), 4 (0.12%) atypical endocervical cells (AECs) and 158 (5.3%) unsatisfactory samples. RR of 2568 smears initially considered negative selected 194 (7.5%) slides. Of the 194, 146 (75.3%) were negative, 28 (14.4%) ASC-US, 5 (2.6%) AEC, 1 (0.5%) LSIL and 14 (7.2%) unsatisfactory. Full review of a 10% random fraction of the 2568 cases interpreted as negative did not detect lesions but did detect 5 (1.95%) unsatisfactory samples.Internal QC used in our laboratory based on clinical and cytomorphologic criteria to select cases for review proved to be an efficient method of detecting HSIL and cervical cancer. The consensus basis of this program strongly limits the false positive and false negative rates and also provides subjects with continuing education. One hundred percent RR is more efficient than 10% full reviewing in detecting cervical abnormalities.por
dc.distributioninternationalpor
dc.identifier.citationMattosinho, G. D. C. F. M., Dall, M. A., Pirani, W. M., Utagawa, M. L., et. al.(2005). 100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratory. Acta cytologica, 49(6), 639-643por
dc.identifier.doi10.1159/000326252por
dc.identifier.eissn1938-2650
dc.identifier.issn0001-5547
dc.identifier.urihttps://hdl.handle.net/1822/67919
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherKarger Publisherspor
dc.relation.publisherversionhttps://www.karger.com/Article/Abstract/326252por
dc.rightsopenAccesspor
dc.subjectBrazilpor
dc.subjectCervical Intraepithelial Neoplasiapor
dc.subjectCytodiagnosispor
dc.subjectFemalepor
dc.subjectHumanspor
dc.subjectLaboratoriespor
dc.subjectMass Screeningpor
dc.subjectMedical Auditpor
dc.subjectPublic Health Practicepor
dc.subjectQuality Assurance, Health Carepor
dc.subjectSensitivity and Specificitypor
dc.subjectUterine Cervical Dysplasiapor
dc.subjectUterine Cervical Neoplasmspor
dc.subjectVaginal Smearspor
dc.subjectPapanicolaou smearpor
dc.subjectCervical cancerpor
dc.subjectHealth care quality assurancepor
dc.subjectQuality controlpor
dc.subjectRapid rescreeningpor
dc.subject.fosCiências Médicas::Medicina Básicapor
dc.subject.wosScience & Technologypor
dc.title100% rapid rescreening for quality assurance in a quality control program in a public health cytologic laboratorypor
dc.typearticlepor
dspace.entity.typePublicationen
oaire.citationEndPage643por
oaire.citationIssue6por
oaire.citationStartPage639por
oaire.citationVolume49por
sdum.journalActa Cytologicapor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
mattosinhodecastroferraz2005.pdf
Tamanho:
77.04 KB
Formato:
Adobe Portable Document Format